HACKENSACK, N.J. (June 26, 2025) — MAX Surgical Specialty Management is proud to announce that 15 oral and maxillofacial surgeons across its network have been named to New Jersey Monthly Magazine’s 2025 list of Top Dentists, as chosen by their peers. This honor reaffirms what we’ve always known — MAX supports the best of the best. The […]
Read more
HACKENSACK, N.J., April 24, 2025 /PRNewswire/ — MAX Surgical Specialty Management (“MAX” or the “Company”), the premier surgeon-led provider of oral and maxillofacial surgery (OMS), announced today that it has closed on a $77 million senior credit facility provided by Freeport Financial Partners, LLC (“Freeport”). The financing will support the next phase of the company’s strategic growth, with a focus on forming new […]
Read more
HACKENSACK, N.J., March 12, 2025 /PRNewswire/ — MAX Surgical Specialty Management (MAX), a surgeon-led support platform for oral and maxillofacial surgery (OMS) practices, has appointed Dr. Margo J. Freedberg as Medical Director and Dr. Sung Hee Cho as Chief Medical Officer. In response to MAX’s expansion across the Northeast, it has enhanced its Clinical Advisory Board to better serve its growing surgeon network, which increased […]
Read more
HACKENSACK, N.J. (Nov. 14, 2024) — MAX Surgical Specialty Management (MAX), the Northeast region’s leading surgeon-led platform providing comprehensive management services for oral and maxillofacial surgery (OMS) practices, has grown to 25 practice locations and increased its surgeon network by nearly 60% in 2024. Its expansion to five states across the Northeast includes new partnerships […]
Read more
Hackensack, New Jersey (August 14, 2024)—MAX Surgical Specialty Management proudly welcomes Brian Lawson as the new Senior Vice President of Business Development. With a 15-year legacy of success in strategy, growth, and M&A across the healthcare industry, Brian’s arrival marks a significant milestone for MAX as it redefines and elevates the delivery of services and […]
Read more
Hackensack, New Jersey (March 20, 2024)—Today, Co-CEO Dr. Jason Auerbach announces Mark Censoprano as the new Co-Chief Executive Officer at MAX Surgical Specialty Management, effective immediately. As Co-CEO, Mark will work alongside Dr. Auerbach to lead MAX’s growth strategy and executive team. Mark’s arrival will accelerate the already exceptional growth that MAX SSM has enjoyed […]
Read more